Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Journal of Clinical Medicine Research|August 14, 2025
Prevalence and Pathogenetic Mechanisms of Chronic Kidney Disease in Autoimmune-Mediated Systemic DiseasesDaniel Patschan, Benedikt Marahrens, Igor Matyukhin, et al.American Journal of Physiology. Renal Physiology|November 16, 2007
Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injuryHaikun Shi, Daniel Patschan, Gunnar P H Dietz, et al.American Journal of Physiology. Heart and Circulatory Physiology|January 22, 2008
Lipid mediators of autophagy in stress-induced premature senescence of endothelial cellsSusann Patschan, Jun Chen, Alla Polotskaia, et al.The Journal of International Medical Research|August 20, 2024
Beta-lactam-associated hypokalemiaMuriel-N Jansen, Wajima Safi, Igor Matyukhin, et al.BMC Nephrology|December 20, 2014
CD4+ lymphocyte adenosine triphosphate--a new marker in sepsis with acute kidney injury?Daniel Patschan, Malte Heeg, Maria Brier, et al.Journal of Clinical Medicine Research|October 12, 2023
Hypernatremia: Epidemiology and Predictive Role in Emerging and Established Acute Kidney InjuryClara Jansch, Igor Matyukhin, Marahrens Marahrens, et al.Journal of Clinical Medicine Research|October 23, 2019
Acute Kidney Injury-Associated Systemic Inflammation Is Aggravated in Insulin-Dependent Diabetes MellitusDaniel Patschan, Katrin Schwarze, Elvira Henze, et al.BMC Rheumatology|July 2, 2026
Metabolomics and cardiovascular risk factors in autoimmune-mediated connective tissue diseases - an exploratory, hypothesis-generating studyEmily Deichsler, Steffen Heelemann, Selina Strathmeyer, et al.Nephron. Clinical Practice|March 15, 2006
OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejectionDaniel Patschan, Andreas Kribben, Frank Pietruck, et al.Journal of Circulating Biomarkers|July 29, 2025
Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritisInga Claus, Meike Hoffmeister, Constantin Remus, et al.Pageof 10